WHWK
Whitehawk Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.91
+0.01 ▲ +0.26%
🌙 3월 13일 7:51 PM ET (한국 3/14 08:51)
$3.81
-0.10 ▼ -2.56%
| Index | - | P/E | 8.24 | EPS (ttm) | 0.47 | Insider Own | 44.4% | Shs Outstand | 0.05B | Perf Week | 4.27% |
| Market Cap | 0.18B | Forward P/E | - | EPS next Y | 2% | Insider Trans | -0.05% | Shs Float | 0.03B | Perf Month | 38.16% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.34 | Inst Own | 54.19% | Short Float | 2.98% | Perf Quarter | 50.97% |
| Income | -0.02B | P/S | 25.85 | EPS this Y | -304.04% | Inst Trans | 5.88% | Short Ratio | 5.46 | Perf Half Y | 94.53% |
| Sales | 0.01B | P/B | 1.35 | EPS next 5Y | - | ROA | -18.59% | Short Interest | 0.78M | Perf YTD | 61.57% |
| Book/sh | 2.89 | P/C | 1.27 | EPS past 3/5Y | 50.16% 58.28% | ROE | -21.82% | 52W High | -12.72% ($4.48) | Perf Year | 102.59% |
| Cash/sh | 3.09 | P/FCF | - | Sales past 3/5Y | -22.27% -13.29% | ROIC | -15.11% | 52W Low | 181.29% ($1.39) | Perf 3Y | -51.12% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 120.71% | Gross Margin | 89.06% | Volatility(W/M) | 8.72% 7.78% | Perf 5Y | -83.91% |
| Dividend TTM | - | EV/Sales | 5.44 | Sales Y/Y TTM | -72.5% | Oper. Margin | -1601.12% | ATR (14) | 0.27 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 10.26 | EPS Q/Q | 50.21% | Profit Margin | -288.26% | RSI (14) | 68.3 | Recom | 1.67 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.26 | Sales Q/Q | -100% | SMA20 | 14.81% ($3.41) | Beta | 0.53 | Target Price | $6.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 30.11% ($3.01) | Rel Volume | 1.52 | Prev Close | $3.9 |
| Employees | 23 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 29.55% - | SMA200 | 71.56% ($2.28) | Avg Volume(3M) | 0.14M | Price | $3.91 |
| IPO | 2017/8/8 | Option/Short | Yes/Yes | Trades | 1376 | Volume | 217,302 | Change | 0.26% |
뉴스 로딩 중...